Showing results (371-380 of 412) with videos related to

Sort By:
Pageof 42
Cell Reports|October 24, 2019
T Cell Repertoire Dynamics during Pregnancy in Multiple SclerosisCaren Ramien, Erik C Yusko, Jan Broder Engler, et al.
Lancet (London, England)|June 8, 2023
Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trialSumanta Kumar Pal, Laurence Albiges, Piotr Tomczak, et al.
Cell Death & Disease|July 31, 2019
Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signalingFelix Seyfried, Salih Demir, Rebecca Louise Hörl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2025
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trialR J Motzer, B Escudier, M Burotto, et al.
Journal of Crohn'S & Colitis|August 30, 2024
Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel DiseaseDominik Roth, Miriam M Düll, Ludwig J Horst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2018
Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized TrialDavid Cella, Bernard Escudier, Nizar M Tannir, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 2015
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometrySaskia J A M Santegoets, Eveline M Dijkgraaf, Alessandra Battaglia, et al.
Leukemia|March 27, 2019
Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Eugen Tausch, Dan A Landau, et al.
The Journal of Clinical Investigation|January 26, 2023
Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosisCarsten Schwarz, Patience Eschenhagen, Henrijette Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trialDavid C Smith, Matthew R Smith, Christopher Sweeney, et al.
Pageof 42